4.7 Review

Might Gut Microbiota Be a Target for a Personalized Therapeutic Approach in Patients Affected by Atherosclerosis Disease?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease

Racha El Hage et al.

Summary: The gut microbiome, particularly its dysbiosis, has a significant impact on human health and disease development. Modulating the gut microbiome has potential for disease prevention and treatment. Dysbiosis increases with age, contributing to gut barrier dysfunction and the release of harmful metabolites such as trimethylamine (TMA). TMA, derived from animal-based food, is oxidized to trimethylamine oxide (TMAO) in the liver and has been associated with several age-related conditions, including peripheral artery disease and vascular aging. Probiotics and prebiotics have shown promise in reducing TMAO levels and atherosclerotic lesions by remodeling the gut microbiota. However, the precise mechanisms and treatments targeting gut dysbiosis and microbiota-derived TMAO in atherosclerosis require further investigation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Nutrition & Dietetics

Neither Trimethylamine-N-Oxide nor Trimethyllysine Is Associated with Atherosclerosis: A Cross-Sectional Study in Older Japanese Adults

Jubo Bhuiya et al.

Summary: Recent evidence suggests that trimethylamine-N-oxide (TMAO), a metabolite of L-carnitine and choline, is linked to atherosclerosis and cardiovascular diseases. However, Japanese people who consume lots of fish, which is high in TMAO, show a low risk of atherosclerosis. This study found that TMAO was not a significant risk factor for atherosclerosis in elderly Japanese people, while a low level of trimethyllysine (TML) might be a potential risk. L-carnitine may be a marker for atherosclerosis in women.

NUTRIENTS (2023)

Review Endocrinology & Metabolism

Association of Gut Microbiota and Diabetes Mellitus

T. Sowmiya et al.

Summary: Diabetes mellitus is a common metabolic disorder affecting 463 million people worldwide, with a projected increase in China, India, and the United States. Gut microbiota has been found to have an association with diabetes, and probiotics have shown anti-diabetic properties. This review aims to explore the role of gut microbiota in diabetes management and the use of probiotics.

CURRENT DIABETES REVIEWS (2023)

Review Biochemistry & Molecular Biology

The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome

Monica Montagnani et al.

Summary: Several studies have shown that the gut microbiota has an influence on behavior, and changes in the immune system associated with symptoms of depression or anxiety disorder may be reflected in corresponding changes in the gut microbiota. However, there is currently no accurate epidemiological evidence explaining the connection between central nervous system (CNS) pathology and intestinal dysbiosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Immunology

The impact of microbially modified metabolites associated with obesity and bariatric surgery on antitumor immunity

Meng Wang et al.

Summary: Obesity is closely related to the occurrence and development of various cancers. Patients with obesity and cancer exhibit disorders in gut microbiota and metabolism, which may hinder the physiological immune response to tumors and potentially harm immune cells in the tumor microenvironment. Bariatric surgery, a recognized effective long-term weight loss strategy, can induce beneficial changes in the gut microbiota. Microbial metabolites, such as short-chain fatty acids (SCFAs), inosine bile acids, and spermidine, have been found to play a significant role in anticancer immunity. This review examines the alterations in microbial metabolites caused by bariatric surgery and discusses their effects on anticancer immunity, aiming to clarify the relationship between these alterations and the effectiveness of cancer treatment while providing strategies for the development of microbial metabolites that mimic the benefits of bariatric surgery to enhance therapeutic outcomes in non-bariatric surgery cancer patients.

FRONTIERS IN IMMUNOLOGY (2023)

Review Biochemistry & Molecular Biology

Free Radicals and Obesity-Related Chronic Inflammation Contrasted by Antioxidants: A New Perspective in Coronary Artery Disease

Carlo Caiati et al.

Summary: We are exposed to increasing levels of free radicals (FR) due to the widespread usage of man-made chemicals, drugs, smoking, processed foods, and various pollutants. These factors, along with obesity and metabolic syndrome, can cause endothelial damage and inflammation. Antioxidants play a crucial role in repairing this damage and preventing atherosclerosis, particularly at the coronary level.

METABOLITES (2023)

Review Infectious Diseases

About Functional Foods: The Probiotics and Prebiotics State of Art

Andrea Ballini et al.

Summary: Poor diet, obesity, and a sedentary lifestyle have a significant impact on natural microbiota disorders, especially the intestinal one, leading to organ dysfunctions. The gut microbiota, which consists of over 500 species of bacteria and contributes to the host's resistance to diseases, has fueled the growing market of functional foods containing probiotics and prebiotics. Advances in DNA sequencing technologies have allowed in-depth characterization of the gut microbiota and its connection to human health and diseases. This study provides a comprehensive investigation of the association between functional foods and the composition of the intestinal microbiota, serving as a foundation for future research in this field.

ANTIBIOTICS-BASEL (2023)

Review Gastroenterology & Hepatology

Microbiota revolution: How gut microbes regulate our lives

Marica Colella et al.

Summary: The human intestine is a complex and dynamic ecosystem of microorganisms called microbiota, which interact with the host and play a crucial role in maintaining host homeostasis. The composition of the microbiota can have both protective and harmful effects on the host health, and dysbiosis can lead to various diseases such as autoimmune diseases, chronic intestinal inflammation, diabetes mellitus, obesity, atherosclerosis, neurological disorders, and colorectal cancer.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Article Oncology

Associations between nutrients in one-carbon metabolism and fetal DNA methylation in pregnancies with or without gestational diabetes mellitus

Isma'il Kadam et al.

Summary: This study aimed to investigate the impact of maternal one-carbon metabolism (OCM) nutrient intakes and levels on fetal DNA methylation and growth patterns in pregnancies with and without gestational diabetes mellitus (GDM). The results showed that maternal choline intake was positively correlated with cord blood corticotropin-releasing hormone (CRH) methylation levels. Higher maternal betaine intake and serum folate levels were associated with lower cord blood and placental insulin-like growth factor 2 (IGF2) DNA methylation. Additionally, maternal betaine intake was inversely associated with infant birth weight.

CLINICAL EPIGENETICS (2023)

Review Nutrition & Dietetics

The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models

Ann M. Centner et al.

Summary: Alterations in the gut microbiome are associated with various chronic conditions, including cardiovascular disease. The diet plays a crucial role in shaping the gut microbiome, as certain foods can affect the abundance of specific microbial populations. Negative changes in the gut microbiome due to a Western diet can lead to arterial inflammation, cell phenotype changes, and plaque accumulation in the arteries. However, interventions with whole foods rich in fiber, phytochemicals, and isolated compounds such as polyphenols and medicinal plants have shown promise in positively influencing the gut microbiome and reducing atherosclerosis.

NUTRIENTS (2023)

Article Cardiac & Cardiovascular Systems

Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis

Marco Witkowski et al.

Summary: The study demonstrates that TMAO increases the risk of cardiovascular events and affects platelets and vascular tissue factor TF. Experimental results indicate that TMAO enhances arterial thrombosis potential by inducing the expression of TF and VCAM1.

CARDIOVASCULAR RESEARCH (2022)

Review Medicine, Research & Experimental

Microbiota medicine: towards clinical revolution

Prisca Gebrayel et al.

Summary: The human gastrointestinal tract is home to a large microbial community called gut microbiota, which plays important roles in immune function, nutrient absorption, and protection against pathogens. The interaction between gut microbiota and various organs within the human body is bidirectional, and microbial alteration has been shown to be a key factor in the pathogenesis of many diseases. Understanding the mechanisms behind gut microbial symbiosis/dysbiosis is crucial for clinical and health fields.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Hematology

Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?

Mehran Ghasemzadeh et al.

Summary: Platelet-leukocyte crosstalk plays a vital role in thrombosis and inflammation. COVID-19, a life-threatening disease, is characterized by intensified interaction between platelets and leukocytes, exacerbating inflammation and thrombosis.

THROMBOSIS RESEARCH (2022)

Review Endocrinology & Metabolism

The Toxic Effects of Endocrine Disrupting Chemicals (EDCs) on Gut Microbiota: Bisphenol A (BPA) A Review

Ioannis Alexandros Charitos et al.

Summary: Research has shown that alterations in gut microbiota caused by exposure to Bisphenol A (BPA) have significant impacts on human health. Experimental evidence has demonstrated that BPA interferes with hormone, homeostatic, and reproductive systems in animals and humans, and disrupts lipid metabolism and pancreatic β-cell functions. Although the estimated exposure levels of BPA from food are lower than the new tolerable daily intake (TDI) value, many international health authorities consider dietary exposure to BPA in adult humans to be safe.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2022)

Article Biochemistry & Molecular Biology

An Antioxidant Supplement Function Exploration: Rescue of Intestinal Structure Injury by Mannan Oligosaccharides after Aeromonas hydrophila Infection in Grass Carp (Ctenopharyngodon idella)

Zhi-Yuan Lu et al.

Summary: This study focused on the protective effects of dietary mannoligosaccharides (MOS) supplementation on the intestinal structural integrity of grass carp. The results showed that dietary MOS supplementation protected the microvillus of the intestine, reduced mucosal permeability, and maintained intestinal structural integrity through the inhibition of MLCK and RhoA/ROCK signaling pathways. These findings highlight the positive impact of dietary MOS supplementation on intestinal health.

ANTIOXIDANTS (2022)

Review Health Care Sciences & Services

The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine

Marina Di Domenico et al.

Summary: The human intestinal microbiota, unique for each individual, changes over time under the influence of various factors. Modulating the intestinal microbiota can positively impact host health, from intestinal diseases to cancer.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis

Martina B. Lorey et al.

Summary: Circulating apolipoprotein B-containing lipoproteins, especially low-density lipoproteins, enter the arterial wall and undergo modifications that induce inflammation, leukocyte diapedesis, and secretion of proinflammatory substances. The composition of lipoprotein particles plays a key role in the extent of retention, modification, and aggregation. Pharmacological interventions can modify these properties for the prevention and treatment of atherosclerotic vascular diseases.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Microbiology

Natural products against inflammation and atherosclerosis: Targeting on gut microbiota

Bing Deng et al.

Summary: The gut microbiota plays a crucial role in human health and disease, especially in atherosclerosis (AS). Targeting the gut microbiota may be a promising therapeutic strategy for AS, and natural products with cardioprotective qualities could offer new avenues for research and treatment by modulating the gut microbiota and its metabolites. However, the specific components and mechanisms of natural products are still unclear.

FRONTIERS IN MICROBIOLOGY (2022)

Article Microbiology

The Composition of Placental Microbiota and Its Association With Adverse Pregnancy Outcomes

Xuena La et al.

Summary: By using 16S rRNA gene sequencing technology, the study examined the placental microbiota and its association with adverse pregnancy outcomes. The results showed that there were fewer bacteria in the placenta, but significant differences were observed in the dominant microbiota between women with and without adverse pregnancy outcomes, such as gestational diabetes mellitus and premature rupture of membranes.

FRONTIERS IN MICROBIOLOGY (2022)

Review Health Care Sciences & Services

The Need for Individualized Risk Assessment in Cardiovascular Disease

Hui Yin Lim et al.

Summary: Despite advancements in the field of cardiovascular disease, currently available clinical markers and tests are not sufficient to predict individual risk. A more precise and complex tool is needed to predict individual thrombosis and bleeding risks, enabling early interventions with a favorable risk-benefit profile. This review explores the fundamental concept of thrombosis and how personalized risk assessment can be improved using various tools.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Biochemistry & Molecular Biology

Microbiota in health and diseases

Kaijian Hou et al.

Summary: The role of microbiota in health and disease is significant, contributing to homeostasis and immune regulation. Dysbiosis of microbiota can lead to disease progression, associated with dysregulation of community composition, modulation of host immune response, and induction of chronic inflammation. Clinical approaches utilizing microbiota, such as microbiota modulation and fecal microbial transplantation, can be effective for disease treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Biochemistry & Molecular Biology

Pathophysiology of Atherosclerosis

Shifa Jebari-Benslaiman et al.

Summary: This article provides an overview of the development of atherosclerosis and discusses the regulatory role of microRNAs and lncRNAs, the role of the microbiota, and the importance of sex as a risk factor.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cardiac & Cardiovascular Systems

The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk

Matthew Nayor et al.

Summary: The development of atherosclerotic cardiovascular disease can be tracked through molecular signatures and imaging methods, providing personalized risk assessment.

CIRCULATION RESEARCH (2021)

Review Biochemistry & Molecular Biology

Role of Macrophages and RhoA Pathway in Atherosclerosis

Malgorzata Kloc et al.

Summary: The development, progression, or stabilization of atherosclerotic plaques depend on the role of pro-inflammatory and anti-inflammatory macrophages. Targeting macrophages and the RhoA pathway could potentially inhibit inflammation, promote tissue remodeling, and contribute to the resolution of atherosclerosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cardiac & Cardiovascular Systems

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy

BingYu Wang et al.

Summary: Atherosclerosis is an inflammatory disease linked to substances like trimethylamine-N-oxide (TMAO) in the gut flora. TMAO is considered an independent risk factor for malignant cardiovascular events, but its impact on patients with cardiovascular diseases remains controversial.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Surgery

Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects

Marwa Abu El Haija et al.

Summary: Toll-like receptor 4 (TLR4) and myeloid differentiation factor 8 (MyD88) play important roles in the metabolic response induced by Roux-en-Y gastric bypass surgery (RYGB), mainly mediated by gut microbiota. TLR4 knockout mice show attenuated glucose regulatory response to RYGB, while MyD88 knockout mice do not respond to the metabolic effects induced by RYGB. Fecal microbiota transplant from RYGB-operated mice fails to induce a metabolic phenotype similar to that of the donors in TLR4 and MyD88 KO mice, but is successful in wild-type recipients.

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Review Nutrition & Dietetics

The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It's Not All Bad

Emily S. Krueger et al.

Summary: Research on TMAO in metabolic diseases plays an important role in understanding its effects on various tissues including the liver, kidney, brain, adipose, and muscle, particularly in atherosclerotic mechanisms. The effects of TMAO on insulin resistance and production may vary, while its impacts on other tissues like pancreatic beta-cells remain largely unexplored. Context-dependent molecular effects of TMAO in metabolic diseases call for further research to clarify both detrimental and beneficial effects observed.

NUTRIENTS (2021)

Review Endocrinology & Metabolism

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

Ygor Parladore Silva et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Nutrition & Dietetics

Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect?

Christopher Papandreou et al.

NUTRIENTS (2020)

Review Cardiac & Cardiovascular Systems

Critical roles of inflammation in atherosclerosis

Junji Moriya

JOURNAL OF CARDIOLOGY (2019)

Article Endocrinology & Metabolism

Dietary lipids, gut microbiota and lipid metabolism

Marc Schoeler et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2019)

Article Medicine, Research & Experimental

L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans

Robert A. Koeth et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Infectious Diseases

Current Issues and Perspectives in Patients with Possible Sepsis at Emergency Departments

Ioannis Alexandros Charitos et al.

ANTIBIOTICS-BASEL (2019)

Article Cardiac & Cardiovascular Systems

Prognostic relevance of subclinical coronary and carotid atherosclerosis in a diabetic and nondiabetic asymptomatic population

Andrea Igoren Guaricci et al.

CLINICAL CARDIOLOGY (2018)

Editorial Material Medicine, General & Internal

Role of the gut microbiota in nutrition and health

Ana M. Valdes et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Editorial Material Medicine, General & Internal

Role of the gut microbiota in nutrition and health

Ana M. Valdes et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Endocrinology & Metabolism

Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?

Giovanni De Pergola et al.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)

Review Medicine, Research & Experimental

Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects

Siddhartha S. Ghosh et al.

TISSUE BARRIERS (2018)

Review Cardiac & Cardiovascular Systems

Role of gut microbiota in atherosclerosis

Annika Lindskog Jonsson et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Peripheral Vascular Disease

Intestinal Immunity and Gut Microbiota in Atherogenesis

Tomoya Yamashita

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)

Article Multidisciplinary Sciences

The gut microbiome in atherosclerotic cardiovascular disease

Zhuye Jie et al.

NATURE COMMUNICATIONS (2017)

Review Nutrition & Dietetics

Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases

Kimberley Lau et al.

NUTRIENTS (2017)

Review Biochemistry & Molecular Biology

Our Gut Microbiome: The Evolving Inner Self

Parag Kundu et al.

Review Cardiac & Cardiovascular Systems

Gut microbiome and its role in cardiovascular diseases

Shadi Ahmadmehrabi et al.

CURRENT OPINION IN CARDIOLOGY (2017)

Article Gastroenterology & Hepatology

Prebiotics: Definition and protective mechanisms

Rosica Valcheva et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Dysbiosis in gastrointestinal disorders

Christopher Chang et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2016)

Review Biochemistry & Molecular Biology

Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis

Aze Wilson et al.

CURRENT OPINION IN LIPIDOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Gut Microbiota and Coronary Artery Disease

Tomoya Yamashita et al.

INTERNATIONAL HEART JOURNAL (2016)

Article Medicine, Research & Experimental

Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery

Marius Troseid et al.

METABOLIC SYNDROME AND RELATED DISORDERS (2016)

Article Food Science & Technology

Lingonberries reduce atherosclerosis in Apoe-/- mice in association with altered gut microbiota composition and improved lipid profile

Chrysoula Matziouridou et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2016)

Review Cardiac & Cardiovascular Systems

Coronary Atherosclerosis: Pathophysiologic Basis for Diagnosis and Management

Konstantinos Dean Boudoulas et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2016)

Article Multidisciplinary Sciences

Unique Features of Ethnic Mongolian Gut Microbiome revealed by metagenomic analysis

Wenjun Liu et al.

SCIENTIFIC REPORTS (2016)

Editorial Material Medicine, General & Internal

Intestinal Microbiome and Atherosclerosis

J. David Spence

EBIOMEDICINE (2016)

Article Microbiology

Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life

Fredrik Backhed et al.

CELL HOST & MICROBE (2015)

Review Cardiac & Cardiovascular Systems

Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases

Tomoya Yamashita et al.

CIRCULATION JOURNAL (2015)

Review Microbiology

Role of gut microbiota in the modulation of atherosclerosis-associated immune response

Dmitry A. Chistiakov et al.

FRONTIERS IN MICROBIOLOGY (2015)

Review Cardiac & Cardiovascular Systems

Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk

Luca Miele et al.

CURRENT CARDIOLOGY REPORTS (2015)

Article Biochemistry & Molecular Biology

Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation

Jill C. Gregory et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Review Environmental Sciences

Childhood Obesity: A Role for Gut Microbiota?

Marina Sanchez et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2015)

Review Medicine, General & Internal

The Epidemic of the 20th Century: Coronary Heart Disease

James E. Dalen et al.

AMERICAN JOURNAL OF MEDICINE (2014)

Review Urology & Nephrology

The Gut Microbiome, Kidney Disease, and Targeted Interventions

Ali Ramezani et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Review Endocrinology & Metabolism

Minireview: Gut Microbiota: The Neglected Endocrine Organ

Gerard Clarke et al.

MOLECULAR ENDOCRINOLOGY (2014)

Article Gastroenterology & Hepatology

Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications

Alejandra de Moreno de LeBlanc et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Cardiac & Cardiovascular Systems

Far from the Eyes, Close to the Heart: Dysbiosis of Gut Microbiota and Cardiovascular Consequences

Matteo Serino et al.

CURRENT CARDIOLOGY REPORTS (2014)

Review Cardiac & Cardiovascular Systems

Gut microbiota metabolism of L-carnitine and cardiovascular risk

John R. Ussher et al.

ATHEROSCLEROSIS (2013)

Review Cardiac & Cardiovascular Systems

Task force on: 'Early markers of atherosclerosis: influence of age and sex'

Marco Matteo Ciccone et al.

JOURNAL OF CARDIOVASCULAR MEDICINE (2013)

Article Biochemistry & Molecular Biology

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Robert A. Koeth et al.

NATURE MEDICINE (2013)

Review Gastroenterology & Hepatology

Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ

Caitriona M. Guinane et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)

Article Immunology

Lipopolysaccharide induces IFN-gamma production in human NK cells

Leonid M. Kanevskiy et al.

FRONTIERS IN IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

The Evolution of Mutualism in Gut Microbiota Via Host Epithelial Selection

Jonas Schluter et al.

PLOS BIOLOGY (2012)

Review Biochemistry & Molecular Biology

Vascular Cell Adhesion Molecule-1 Expression and Signaling During Disease: Regulation by Reactive Oxygen Species and Antioxidants

Joan M. Cook-Mills et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Review Pharmacology & Pharmacy

Inflammatory Markers in Hyperlipidemia: From Experimental Models to Clinical Practice

Gerasimos Siasos et al.

CURRENT PHARMACEUTICAL DESIGN (2011)

Review Pharmacology & Pharmacy

Pathophysiology of Atherosclerosis: The Role of Inflammation

Dimitris Tousoulis et al.

CURRENT PHARMACEUTICAL DESIGN (2011)

Article Multidisciplinary Sciences

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Zeneng Wang et al.

NATURE (2011)

Article Multidisciplinary Sciences

Human oral, gut, and plaque microbiota in patients with atherosclerosis

Omry Koren et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Medicine, General & Internal

Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism

R. Caesar et al.

JOURNAL OF INTERNAL MEDICINE (2010)

Review Gastroenterology & Hepatology

Microbes in Gastrointestinal Health and Disease

Andrew S. Neish

GASTROENTEROLOGY (2009)

Review Radiology, Nuclear Medicine & Medical Imaging

Role of inflammation in atherosclerosis

Luigi Giusto Spagnoli et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

Article Multidisciplinary Sciences

Diversity of the human intestinal microbial flora

PB Eckburg et al.

SCIENCE (2005)

Article Cell Biology

Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells

PJ Kuhlencordt et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)